$500B+ Immunotherapy Market by 2030
CAR-T Cell Therapy Optimization
CRS Cytokine Storm Prediction
FDA 3.0 Human Immune Models
Checkpoint Inhibitor Testing
BiTE T-Cell Engager Assays
TME Tumor Microenvironment
PD-1/L1 Immune Checkpoint
$500B+ Immunotherapy Market by 2030
CAR-T Cell Therapy Optimization
CRS Cytokine Storm Prediction
FDA 3.0 Human Immune Models
Checkpoint Inhibitor Testing
BiTE T-Cell Engager Assays
TME Tumor Microenvironment
PD-1/L1 Immune Checkpoint
Human Immune System on a Chip

Immune Response.
Engineered.

Human T-cell and immune system-on-chip platform for immunotherapy development, CAR-T optimization, and immunotoxicity prediction. Your immune system, in vitro.

T TUMOR TUMOR TUMOR TUMOR CYTOLYTIC ACTIVITY 85% KILL RATE CAR CD19
$500B
Immunotherapy Market 2030
6
FDA-Approved CAR-Ts
30%
CRS Rate Reduction Goal
100x
vs Mouse Models

Immune System Platform

Complete human immune function modeling for next-generation immunotherapy development.

??

CAR-T Optimization

Evaluate CAR constructs, co-stimulatory domains, and manufacturing conditions with patient-derived T-cells.

??

CRS Prediction

Cytokine release syndrome risk assessment through IL-6, TNF-alpha, and IFN-gamma profiling.

???

Checkpoint Inhibitors

PD-1/PD-L1, CTLA-4, and emerging checkpoint targets in human tumor microenvironment models.

??

BiTE/TCE Assays

Bispecific T-cell engager efficacy and cytokine release in physiologically relevant 3D systems.

??

Immunotoxicity

Hypersensitivity, autoimmunity, and immunosuppression assessment on human immune cells.

??

TME Modeling

Tumor microenvironment with immune infiltrates, MDSCs, Tregs, and stromal components.

Therapeutic Applications

Advancing the entire immunotherapy pipeline from discovery to clinic.

??

CAR-T Cell Therapies

Optimize chimeric antigen receptor design and manufacturing

??

Checkpoint Inhibitors

PD-1, PD-L1, CTLA-4, LAG-3, TIM-3 antibody testing

??

T-Cell Engagers

BiTEs, DARTs, and other bispecific formats

??

Oncolytic Viruses

Immune activation and tumor lysis assessment

Industry Leaders

Organizations advancing immune system-on-chip technology.

Emulate Immune-Chip
Lymphoid follicle chip for vaccine and immunotherapy testing
Hesperos Immuno-Onc
Multi-organ immune system with tumor co-culture
Mimetas TME
Tumor-immune microenvironment in OrganoPlate
Cherry Biotech Live Imaging
Real-time T-cell killing visualization platforms
AIM Biotech 3D Models
Microfluidic 3D tumor-immune interaction assays
Xilis Organoids
MicroOrganoSpheres with immune cell infiltration

Own Immuno-Oncology

T-CellChip.com - the premium domain for immune system-on-chip technology and immunotherapy development.

Inquire About This Domain

Own Tcellchip

This premium domain is available for acquisition. Perfect for companies, startups, or investors in this space.

Submit your inquiry below and we'll respond within 24 hours.